DTNA

Chr 18AD

dystrobrevin alpha

Also known as: D18S892E, DRP3, DTN, DTN-A, LVNC1, MMCKR2

The protein is a component of the dystrophin-associated protein complex that localizes to the sarcolemma and may be involved in synapse formation and acetylcholine receptor clustering. Autosomal dominant mutations cause left ventricular noncompaction with or without congenital heart defects, and myopathy with myalgia, elevated creatine kinase, and episodic rhabdomyolysis. The gene is moderately constrained against loss-of-function variants (LOEUF 0.368).

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 0.372 OMIM phenotypes
Clinical SummaryDTNA
🧬
Gene-Disease Validity (ClinGen)
congenital heart disease · ADDisputed

Disputed — evidence questions this relationship

2 total gene-disease associations curated

Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.63) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
15 unique Pathogenic / Likely Pathogenic· 247 VUS of 510 total submissions
📖
GeneReview available — DTNA
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.37LOEUF
pLI 0.635
Z-score 4.78
OE 0.21 (0.130.37)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.42Z-score
OE missense 0.80 (0.730.88)
327 obs / 407.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.21 (0.130.37)
00.351.4
Missense OE0.80 (0.730.88)
00.61.4
Synonymous OE1.00
01.21.6
LoF obs/exp: 9 / 42.7Missense obs/exp: 327 / 407.7Syn Z: 0.01
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedDTNA-related dilated cardiomyopathyOTHERAD
DN
0.7131th %ile
GOF
0.77top 25%
LOF
0.4825th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

510 submitted variants in ClinVar

Classification Summary

Pathogenic14
Likely Pathogenic1
VUS247
Likely Benign188
Benign38
Conflicting8
14
Pathogenic
1
Likely Pathogenic
247
VUS
188
Likely Benign
38
Benign
8
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
13
0
14
Likely Pathogenic
0
0
1
0
1
VUS
19
191
31
6
247
Likely Benign
0
5
92
91
188
Benign
0
3
35
0
38
Conflicting
8
Total1920017297496

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

DTNA · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗